###begin article-title 0
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
The Toll-Like Receptor Signaling Molecule Myd88 Contributes to Pancreatic Beta-Cell Homeostasis in Response to Injury
###end article-title 0
###begin p 1
Conceived and designed the experiments: PLB IRS JAG TRH GTN. Performed the experiments: PLB JBB IRS BAF VHG AEC. Analyzed the data: PLB JBB IRS. Contributed reagents/materials/analysis tools: AA TRH GTN. Wrote the paper: PLB JBB TRH.
###end p 1
###begin p 2
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 369 377 363 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 438 446 432 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 618 626 612 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 691 696 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 1086 1091 1077 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
Commensal flora and pathogenic microbes influence the incidence of diabetes in animal models yet little is known about the mechanistic basis of these interactions. We hypothesized that Myd88, an adaptor molecule in the Toll-like-receptor (TLR) pathway, regulates pancreatic beta-cell function and homeostasis. We first examined beta-cells histologically and found that Myd88-/- mice have smaller islets in comparison to C57Bl/6 controls. Myd88-/- mice were nonetheless normoglycemic both at rest and after an intra-peritoneal glucose tolerance test (IPGTT). In contrast, after low-dose streptozotocin (STZ) challenge, Myd88-/-mice had an abnormal IPGTT relative to WT controls. Furthermore, Myd88-/- mice suffer enhanced beta-cell apoptosis and have enhanced hepatic damage with delayed recovery upon low-dose STZ treatment. Finally, we treated WT mice with broad-spectrum oral antibiotics to deplete their commensal flora. In WT mice, low dose oral lipopolysaccharide, but not lipotichoic acid or antibiotics alone, strongly promoted enhanced glycemic control. These data suggest that Myd88 signaling and certain TLR ligands mediate a homeostatic effect on beta-cells primarily in the setting of injury.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Takeda1">[1]</xref>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 469 472 465 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Adachi1">[2]</xref>
###xml 474 477 470 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Kawai1">[3]</xref>
Toll-like receptors (TLRs) recognize structurally conserved microbial products and mediate the initiation of inflammatory and immune defense responses [1]. All TLRs, with the exception of TLR3, can signal via the adaptor Myd88, leading to activation of NF-kappaB as well as mitogen-activated protein (MAP) kinase pathways. These pathways have been shown to regulate immune response genes such as cytokines and chemokines that modulate both innate and adaptive immunity [2], [3].
###end p 4
###begin p 5
###xml 220 223 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Jiang1">[4]</xref>
###xml 231 234 231 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Seki1">[5]</xref>
###xml 241 244 241 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Macedo1">[6]</xref>
###xml 260 263 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-RakoffNahoum1">[7]</xref>
###xml 454 457 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-vanTol1">[8]</xref>
###xml 464 467 461 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Li1">[9]</xref>
###xml 475 479 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Putnins1">[10]</xref>
###xml 486 490 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Sanale1">[11]</xref>
###xml 496 500 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Sugiyama1">[12]</xref>
###xml 520 524 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Uematsu1">[13]</xref>
In conjunction with their role in host defense, TLRs also play concomitant roles limiting tissue damage and promoting wound healing at sites of injury. This has been demonstrated for multiple tissue types including lung [4], liver [5], skin [6], and intestine [7]. Components of microbial pathogens interact with TLRs to promote production of several protective factors relevant to cytoprotection, tissue repair and angiogenesis. These include TGF-beta1 [8], VEGF [9], KGF-1 [10] KGF-2 [11], HGF [12] and prostaglandins [13].
###end p 5
###begin p 6
###xml 120 123 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-RakoffNahoum1">[7]</xref>
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Seki1">[5]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Thomas1">[14]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Franchimont1">[15]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Clevers1">[16]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Rivera1">[17]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Ley1">[18]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Cani1">[19]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Membrez1">[20]</xref>
###xml 438 444 <span type="species:ncbi:10090">murine</span>
In the gut commensal flora-derived TLR ligands have been proposed to play a homeostatic role in steady state conditions [7]. TLRs contribute to liver regeneration [5] and are implicated in the pathogenesis of many chronic GI disorders, including celiac disease [14], inflammatory bowel disease [15], colon cancer [16] and non-alcoholic steatohepatitis [17]. Gut flora has also been suggested to contribute to obesity [18] and diabetes in murine models [19], [20].
###end p 6
###begin p 7
###xml 74 78 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-VivesPi1">[21]</xref>
###xml 80 84 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Wen1">[22]</xref>
###xml 281 285 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Takahashi1">[23]</xref>
###xml 287 291 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Sai1">[24]</xref>
###xml 293 297 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Balasa1">[25]</xref>
###xml 299 303 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Alyanakian1">[26]</xref>
###xml 305 309 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Brugman1">[27]</xref>
###xml 337 341 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-vander1">[28]</xref>
###xml 343 347 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Sobel1">[29]</xref>
###xml 349 353 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Serreze1">[30]</xref>
###xml 355 359 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Uematsu2">[31]</xref>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Although human and mouse beta-cells are known to express TLR2, 3, 4 and 9 [21], [22], little is known about their role in pancreas beta-cell physiology and diabetes. Data are largely limited to autoimmune diabetes models. In this context various bacterial extracts and antibiotics [23], [24], [25], [26], [27], as well as viral mimetics [28], [29], [30], [31] have been found to impact the incidence of disease, presumably by impacting on beta-cell specific immune tolerance.
###end p 7
###begin p 8
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Wen2">[32]</xref>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 458 463 <span type="species:ncbi:10090">mouse</span>
A recent study examined the role of Myd88 in the incidence of autoimmune diabetes in Non-Obese Diabetic (NOD) mice [32]. Those authors found that NOD Myd88-/- mice were protected from diabetes under sterile pathogen free (SPF) conditions but not under gnotobiotic conditions. Furthermore, the gnotobiotic-reared NOD Myd88-/- mice were protected from diabetes by exposure to SPF gut flora. These data cast new light on the observation that cleanliness in NOD mouse colonies directly relates to diabetes incidence and suggest that gut flora may act as an important tolerizing agent. However, these data are specific to autoimmunity mediated by cytotoxic lymphocytes and do not address any role that Myd88-/- and TLR might regularly play in beta-cell development and injury responses under normal (e.g. non-autoimmune prone) circumstances.
###end p 8
###begin p 9
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
In this work we have examined the role of TLRs in beta-cell physiology in a non-autoimmune prone model, the C57Bl/6 mouse. We hypothesized that TLR-microbial interactions play a role in beta-cell development and homeostasis and that these effects might be particularly relevant in settings of injury. This research highlights an important connection between microbial products and pancreas beta-cell homeostasis in which beta cell resistance to damage-associated apoptosis is mediated by a TLR dependent pathway.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 11
###begin p 12
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2&#8722;/&#8722;</italic>
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr4&#8722;/&#8722;</italic>
###xml 98 101 98 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Adachi1">[2]</xref>
###xml 157 164 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr5&#8722;/&#8722;</italic>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Uematsu2">[31]</xref>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR3&#8722;/&#8722;</italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">Mice</span>
Myd88-/-, TLR2-/-, Tlr4-/-, mice (129SvJxC57Bl/6 background) were derived as previously described [2] and backcrossed for six generations with C57Bl/6 mice. Tlr5-/- mice were derived and backcrossed to a C57Bl/6 background for eight generations as previously described [31]. TLR3-/- pancreases were provided by Dr. Richard Flavell at Yale University. Wild type C57Bl/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were maintained in the specific pathogen-free AAALAC-accredited animal facility at the Benaroya Research Institute or at the Institute for Systems Biology and handled in accordance with institutional guidelines. All animal work was approved by the Benaroya Research Institute (BRI) Animal Care and Use Committee (ACUC), and the Institute for Systems Biology Animal Care and Use Committee.
###end p 12
###begin title 13
Reagents
###end title 13
###begin p 14
###xml 26 38 26 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. minnesota</italic>
###xml 88 97 88 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 26 38 <span type="species:ncbi:70803">S. minnesota</span>
###xml 45 48 <span type="species:ncbi:9685">cat</span>
###xml 88 97 <span type="species:ncbi:411806|species:ncbi:1280|species:ncbi:78380|species:ncbi:211046|species:ncbi:193461|species:ncbi:170984|species:ncbi:507602|species:ncbi:98688">S. aureus</span>
###xml 99 102 <span type="species:ncbi:9685">cat</span>
###xml 129 132 <span type="species:ncbi:9685">cat</span>
###xml 155 158 <span type="species:ncbi:9685">cat</span>
###xml 185 188 <span type="species:ncbi:9685">cat</span>
###xml 209 212 <span type="species:ncbi:9685">cat</span>
###xml 235 238 <span type="species:ncbi:9685">cat</span>
Lipopolysaccharide (LPS) (S. minnesota R595)(cat. #L9764), lipoteichoic acid (LTA) from S. aureus (cat. #L2515), streptozotocin (cat. #S0130), vancomycin (cat. #861987), metronidazole (cat. #M3761), neomycin (cat. #N1876), ampicillin (cat. # A9518) were all obtained from Sigma-Aldrich (St. Louis, MO).
###end p 14
###begin title 15
Blood Glucose Measurement
###end title 15
###begin p 16
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">Mice</span>
Blood glucose was performed via saphenous vein bleeds using a One-Touch FastTake glucometer (LifeScan, Milpitas, CA). For intraperitoneal glucose tolerance tests (IPGTT), mice were fasted (given water only) for 8-12 h. Mice were then injected intraperitoneally with 1.0 mg/ml d-glucose (stock solution in PBS) at a dose of 1 g/kg body weight. Saphenous blood glucose readings were taken at 0, 30, 60 and 120 minutes post injection.
###end p 16
###begin title 17
Histologic Studies
###end title 17
###begin p 18
###xml 329 339 <span type="species:ncbi:10141">guinea pig</span>
###xml 345 348 <span type="species:ncbi:9823">pig</span>
Animals were sacrificed under anesthesia and pancreatic and liver tissues were frozen in Tissue-Tek OCT embedding media (Sakura Finetek, Torrance, CA). For staining of frozen tissues, 6 microm tissue slices were fixed in 10% neutral-buffered formalin, processed and embedded in paraffin. Staining was performed with a polyclonal guinea pig anti-pig insulin antibody (DAKO, Insulin A0564) at 1:100 after 20 minute citrate heat induced epitope retrieval with an HRP labeled polymer visualization kit (DAKO, EnVision+ K4010) following the manufacturer recommended staining protocol. Slides were then counterstained with hematoxylin, cleared and mounted.
###end p 18
###begin title 19
Evaluation of beta-cell volume and mass
###end title 19
###begin p 20
###xml 199 203 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Weibel1">[33]</xref>
###xml 253 257 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Montana1">[34]</xref>
###xml 259 263 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Pick1">[35]</xref>
###xml 265 269 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Xu1">[36]</xref>
###xml 385 392 382 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005063-t001">Table 1</xref>
###xml 854 861 847 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005063-t001">Table 1</xref>
###xml 901 905 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Collins1">[37]</xref>
###xml 319 324 <span type="species:ncbi:10090">mouse</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 834 839 <span type="species:ncbi:10090">mouse</span>
Quantification of beta-cell volume and mass were performed by point-counting morphometry of insulin-immunostained pancreatic sections, with minor adaptation to the method described by Weibel et. al. [33], and later applied by Bonner-Weir and colleagues [34], [35], [36]. The number of pancreases used per each breed of mouse as well as the ages and weights of the mice are detailed in Table 1. For each pancreas, an average of 6 independent sections at least 100 microm apart were analyzed. Each section was covered systematically using a digital camera (Diagnostic Instruments, Sterling Height, MI) attached to a Leica DM-IRB microscope (Leica Microsystems, Wetzlar, Germany). Approximately 200 non-overlapping fields from an average of 6 sections were evaluated per pancreas. Between 2-5 pancreases were evaluated for each breed of mouse in the study (Table 1). The ImageJ software computer program [37] was used to superimpose a 99 point grid over each image. The number of intercepts over beta-cells and over non-beta-cell pancreatic tissue was counted. The relative beta-cell volume was calculated by dividing the intercepts over beta-cells by the intercepts over total pancreatic tissue. This number was multiplied by the total mass of the pancreas to arrive at the total beta-cell mass for the pancreas in question. Islet number was calculated on a per field basis using the same fields as were used to calculate relative beta-cell volume. The definition of an islet was chosen as a cluster of insulin positive cells with a minimum of four visible nuclei
###end p 20
###begin title 21
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Characteristics of mouse populations used for histological analysis of WT and TLR KO strains.
###end title 21
###begin p 22
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Differences between strains were not significant. TLR3 mice were not weighed prior to their being sacrificed.
###end p 22
###begin title 23
Islet isolation and culture
###end title 23
###begin p 24
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anesthetized by intraperitoneal injection of sodium pentobarbital (35 mg/230 g body wt). Islets were prepared by injecting collagenase (10 ml of 0.23 mg/ml liberase; Roche Molecular Biochemicals, Indianapolis, IN) into the pancreatic duct and surgically removing the pancreas. The pancreases were placed into 15-ml conical tubes containing 5 ml of 0.23 mg/ml liberase and incubated at 37degreesC for 30 min. The digestate was filtered (400 microm stainless steel screen), rinsed (Hank's buffered salt solution), and purified in a gradient solution of Optiprep (Nycomed, Oslo, Norway). Islets were cultured for 18-24 h in RPMI media 1640 supplemented with 10% heat inactivated FBS before further experimentation. All procedures were approved by the University of Washington Internal Animal Care and Use Committee.
###end p 24
###begin title 25
Evaluation of Islet size
###end title 25
###begin p 26
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Ricordi1">[38]</xref>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
Individual islets were evaluated for size by dithizone staining [38] and their diameter was scored as <50, <100, <150, <200, <250, <300 using a grid marked at 50 uM increments. A total of 167 islets from 2 WT mice and 198 islets from 3 Myd88-/- mice were assessed in this manner.
###end p 26
###begin title 27
Islet response to glucose challenge
###end title 27
###begin p 28
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Shapiro1">[39]</xref>
###xml 258 259 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 262 263 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 285 286 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 305 306 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 752 753 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 875 880 <span type="species:ncbi:9606">human</span>
Islet function was assessed by monitoring the insulin secretory response of the purified islets according to the procedure described by the Edmonton group [39]. Islets were washed twice in 3 mM glucose Krebs-Ringer bicarbonate (KBR) solution (2.6 mmol/l CaCl2/2H2O, 1.2 mmol/l MgSO4/7H2O, 1.2 mmol/l KH2PO4, 4.9 mmol/l KCl, 98.5 mmol/l NaCl, and 25.9 mmol/l NaHCO3 (all from Sigma-Aldrich, St. Louis, MO) supplemented with 20 mmol/l HEPES/NaHEPES (Roche Molecular Biochemicals, Indianapolis, IN) and 0.1% BSA (Serological, Norcross, GA). 40 islets per condition were placed into a 96 well plate (10 islets per well in quadruplicate) containing 200 microl of either 3 mM glucose KRB or 20 mM glucose KRB and incubated for 2 hours at 37degreesC and 5% CO2. The supernatant was collected for insulin measurement. Insulin concentrations in these experiments were analyzed with a human insulin enzyme-linked immunosorbent assay (ELISA) kit (ALPCO Insulin ELISA kit, Windham, NH).
###end p 28
###begin title 29
Streptozotocin Treatment
###end title 29
###begin p 30
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 141 145 <span type="species:ncbi:10090">Mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">Mice</span>
###xml 610 614 <span type="species:ncbi:10090">Mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">Mice</span>
Mice were treated with STZ at 40 mg/kg/day intraperitoneally for 4 consecutive days. STZ was administered within 10 min. of its dissolution. Mice in the untreated control group received citrate buffer (vehicle) alone. IPGTT was performed on fasted mice on days 0, 11, 18, and 25 following the initiation of the 4 day STZ treatment course. Animals were monitored for diabetes by obtaining periodic blood samples from the tail vein of non-fasted mice and glucose was measured by a blood glucose meter. Mice were considered diabetic when non-fasting blood glucose levels were >200 mg/dl for two consecutive days. Mice were weighed every other day for the determination of percent weight change and any mice with a >10% weight loss were sacrificed. Weight loss was calculated as: % weight change = (weight at day X-day 0/weight at day 0)x100. Animals were monitored clinically for rectal bleeding, diarrhea, and general signs of morbidity, including hunched posture and failure to groom. No mice became frankly diabetic, lost more than 10% of body weight, or died on this protocol. Mice were anesthetized and pancreases were removed at several time points following the start of STZ treatment including days 0, 7, 14, and 21.
###end p 30
###begin title 31
TUNEL Staining and apoptosis quantification
###end title 31
###begin p 32
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 434 444 <span type="species:ncbi:10141">guinea pig</span>
###xml 520 524 <span type="species:ncbi:9925">goat</span>
###xml 530 540 <span type="species:ncbi:10141">guinea pig</span>
Frozen tissues were cut (5 microm), fixed (4% paraformaldehyde), permeabilized (Triton X-100), and stained using a TUNEL cell death detection kit (terminal-deoxynucleotidyl-transferase-mediated dUTP Nick End Labeling, Roche Diagnostics GmbH, Mannheim, Germany). Positive controls with DNase (Invitrogen, Carlsbad, CA) and negative controls with Day 0 mice and only TUNEL label solution were used. For the insulin staining, polyclonal guinea pig anti-insulin antibody (Abcam, Cambridge, MA) and AlexaFlour 568-conjugated goat anti-guinea pig fluorescent antibody (Molecular Probes, Eugene, OR) were applied in separate incubation steps for 1 hour at 37degreesC following TUNEL staining. Slides were coverslipped using VectaShield hard mount with DAPI (Vector Laboratories, Burlingame, CA). All pancreatic tissue slides were imaged using a Leica DM-IRB (Leica Microsystems, Wetzlar, Germany) fluorescent microscope equipped with a 4-Megapixel CCD SPOT digital camera (Diagnostic Instruments, Sterling Height, MI) and merged using SPOT advanced imaging software. Islet morphology was identified from the insulin and DAPI staining. Apoptotic cells within islets were counted from the merged images as DAPI nuclei with positive TUNEL staining. No insulin negative apoptotic cells were identified.
###end p 32
###begin title 33
Glucagon-like peptide 1 (GLP-1) measurement
###end title 33
###begin p 34
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 156 159 <span type="species:ncbi:9685">Cat</span>
Separate blood samples taken from fasting mice and then 90 minutes post-glucose challenge were added to ice-cooled tubes containing EDTA. DPP-IV inhibitor (Cat # DPP4)(Linco, St. Charles, MO) was added at 10 ul per ml of blood. The samples were centrifuged within 30 minutes of blood collection and plasma was removed and stored samples at -20degreesC. GLP-1 was subsequently measured using an ELISA kit (Linco, St. Charles, MO) according to the manufacturer's instructions.
###end p 34
###begin title 35
Depletion of gut commensal microflora and reconstitution of commensal-depleted animals with TLR ligands
###end title 35
###begin p 36
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-RakoffNahoum1">[7]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Fagarasan1">[40]</xref>
###xml 1012 1021 996 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 79 83 <span type="species:ncbi:10090">Mice</span>
###xml 1012 1021 <span type="species:ncbi:411806|species:ncbi:1280|species:ncbi:78380|species:ncbi:211046|species:ncbi:193461|species:ncbi:170984|species:ncbi:507602|species:ncbi:98688">S. aureus</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
WT animals were depleted of commensals using a 4-week oral antibiotic regimen. Mice were provided ampicillin (1 g/L), vancomycin (500 mg/L), neomycin sulfate (1 g/L), and metronidazole (1 g/L) in drinking water for four weeks prior to beginning STZ treatment and for the duration of the experiment. This protocol was based on previously described depletion protocols [7], [40]. For the determination of colonic microflora, fecal matter was removed from colons using sterile technique, placed in 15 ml conical tubes with thyoglycolate, and vortexed until homogenous. Contents were diluted and plated on universal and differential media for the growth of anaerobes and aerobes in the clinical microbiology lab in the Department of Laboratory Medicine of Virginia Mason Medical Center. After counting, colonies were picked and identified by biochemical analysis, morphologic appearance, and Gram staining. At week 3, drinking water was supplemented with 10 microg/microl, or 10 ng/microl of LPS or 100 ng/microl of S. aureus LTA and was continued in drinking water for the duration of the experiment. Eight age and gender matched mice were in each experimental arm. STZ treatment was initiated as described above.following depletion of intestinal flora.
###end p 36
###begin title 37
Statistical Analysis
###end title 37
###begin p 38
Statistical analysis was performed using a Student's t test except for the comparison of islet size distributions, where a Kolmogorov-Smirnov (KS) test was used. P values<0.05 were considered significant. Error bars represent+/-SEM.
###end p 38
###begin title 39
Results
###end title 39
###begin title 40
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Myd88-/- mice have reduced beta-cell volume and islet size
###end title 40
###begin p 41
###xml 272 277 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
To test the hypothesis that TLR signaling was critical for beta-cell homeostasis, we first examined the impact of TLR signaling on pancreatic beta-cell size and function in the absence of injury. We looked for phenotypic differences between WT mice and knock-out mice for Myd88, TLR2, TLR3, TLR4 and TLR5.
###end p 41
###begin p 42
###xml 277 284 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005063-t001">Table 1</xref>
###xml 303 308 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 426 435 420 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g001">Figure 1C</xref>
###xml 531 540 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g001">Figure 1D</xref>
###xml 559 564 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 651 656 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 696 705 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g001">Figure 1E</xref>
###xml 796 801 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 500 505 <span type="species:ncbi:10090">mouse</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
We focused initially on islet cell mass and volume because the cell mass of islets present in the pancreas, particularly that of beta-cells, plays an essential role in determining the amount of insulin secreted. The numbers, ages and body weights of the mice used are shown in Table 1. Both TLR2-/- and Myd88-/- mice were found to have significantly smaller relative beta-cell volume as a percentage of total pancreas volume (Figure 1C). However, the number of islets per field between the different mouse strains remained intact (Figure 1D), suggesting that Myd88-/- islets were smaller than WT islets. When total beta-cell mass was calculated, only Myd88-/- mice had diminished beta-cell mass (Figure 1E). Therefore, in our subsequent work, we elected to focus solely on the comparison between Myd88-/- and WT animals.
###end p 42
###begin title 43
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Histologic measurement of beta-cell volume, mass and islet number for WT and TLR KO mice.
###end title 43
###begin p 44
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 308 315 302 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005063-t001">Table 1</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 74 81 <span type="species:ncbi:10703">C. beta</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
A&B Representative histological sections from A) Myd88-/- and B) B6 mice. C. beta-cell volume as a percentage of total pancreas volume. D. Islet cell number per histologic field examined. E. Total beta-cell mass. The ages, body weights, and pancreatic weights of the mice used for these studies are shown in Table 1. * = p<0.05.
###end p 44
###begin p 45
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 107 116 107 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g002">Figure 2A</xref>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 233 242 233 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g002">Figure 2B</xref>
###xml 333 338 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 376 381 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 349 354 <span type="species:ncbi:10090">mouse</span>
This histologic finding of smaller Myd88-/- islets was born out by measurements of islet diameter ex vivo (Figure 2A). Pooled islets from Myd88-/- mice tended to have less insulin content, though this difference was not significant (Figure 2B). Together these data demonstrate a difference in beta-cell volume and islet size between Myd88-/- and WT mouse strains and suggests Myd88 may play a role in the regulation of beta-cell mass.
###end p 45
###begin title 46
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Size Distribution of Islets and pooled islet insulin content in WT versus Myd88-/- mice.
###end title 46
###begin p 47
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
A. Islets were harvested from Myd88-/- (3 mice) and WT (2 mice) animals and were graded by size. The two size distributions were significantly different (p = 0.027). B. Total insulin content of pooled WT versus Myd88-/- islets. Four groups of 10 size-matched islets were compared in each group. Differences between the groups were not significant.
###end p 47
###begin title 48
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Uninjured Myd88-/- mice do not demonstrate impaired glycemic control
###end title 48
###begin p 49
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 301 310 301 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g003">Figure 3A</xref>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x vivo</italic>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 537 546 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g003">Figure 3B</xref>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
To examine the functional relevance of this difference in islet size, we measured fasting glucose as well as after an intraperitoneal glucose challenge (IPGTT) in Myd88-/- and WT mice. We found no difference between the two groups in fasting blood glucose or peak blood glycemia upon IPGTT challenge (Figure 3A). Ex vivo evaluation of insulin production by WT and Myd88-/- islets matched for size likewise demonstrated no difference between the two strains upon stimulation with either low (3 mM) or high (20 mM) glucose concentrations (Figure 3B). We therefore concluded that while Myd88-/- animals have islets of smaller size this did not appear to have any functional consequence in otherwise healthy animals.
###end p 49
###begin title 50
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
Response to glucose challenge in vivo and ex vivo.
###end title 50
###begin p 51
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 842 847 <span type="species:ncbi:10090">mouse</span>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
A. Pooled data are shown for IPGTT performed on 47 WT mice and 41 Myd88-/- mice. Only the 30 min time-point comparison was significant. All mice were between 10 and 20 weeks of age. The mean age was 15.5 (+/-2.1) weeks for WT mice and 16.0 (+/-3.8) weeks for Myd88-/- mice. The mean weight was 24.75 (+/-3.5) gms for WT mice and 23.4 (+/-3.6) gms for Myd88-/- mice. These differences in age and weight were not significant. 34% of the WT mice were female while 43% of the WT mice were female. IPGTT test results were not significantly different between the two genders. B. Insulin secretion in response to glucose challenge. Both total insulin content and insulin response to glucose challenge were determined in paired experiments using islets from the same pair of mice. 10 islets per well were assessed in quadruplicate per condition, per mouse. Data shown are representative of two experiments. There was no significant difference between the two strains of mice.
###end p 51
###begin title 52
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Myd88-/- mice treated with STZ demonstrate impaired glycemic control and transaminitis
###end title 52
###begin p 53
###xml 396 401 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
We next hypothesized that small decreases in beta-cell mass mediate altered glucose regulation in settings of borderline glycemic control. We therefore designed experiments to stress animals into borderline glycemic control conditions to evaluate the functional relevance of the aforementioned decreases in islet cell size and mass. We administered 4 days of low-dose (40 mg/kg) STZ treatment to Myd88-/- and WT controls. While high dose STZ protocols (e.g. 200 mg/kg) reliably induce diabetes in C57Bl/6 mice in our experiment, our intention was to administer a sub-diabetogenic dose which might impact glycemic control of the two strains of mice differently. Following STZ treatment, we monitored the mice with weeklyat 0, 7, 14 and 24 days with IPGTT over a three week period.
###end p 53
###begin p 54
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 112 123 112 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g004">Figure 4A&#8211;D</xref>
###xml 246 255 246 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g004">Figure 4A</xref>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g004">Figure 4B</xref>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 470 479 470 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g004">Figure 4C</xref>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
We found that Myd88-/- mice developed significant hyperglycemia relative to WT controls upon glucose challenge (Figure 4A-D). This was the case for both the 30 minute and 60 minute IPGTT time points on day 11 (7 days after the final dose of STZ)(Figure 4A) as well as for the 60 minute time point for day 18 (14 days after the last dose of STZ)(Figure 4B). The Myd88-/- mice did, however, recover normal glycemic control by day 28 (24 days after the final dose of STZ) (Figure 4C) consistent with healing. Of note, Myd88-/- mice did not reliably develop hyperglycemic responses to IPGTT upon treatment with 3 days of low-dose STZ treatment (data not shown), suggesting a threshold with the 4-day regimen.
###end p 54
###begin title 55
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
IPGTT for WT and Myd88-/- mice treated with STZ.
###end title 55
###begin p 56
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
Data shown are for 8 WT mice and 8 Myd88-/- mice who received low-dose STZ treatment for 4 days. IPGTT data are shown for this same group of mice 7 days (A), 14 days (B) and 24 days (C) following completion of the STZ treatment course. All mice were between 12 and 16 weeks of age and were evenly split between male and female genders. The mean weight was 21.3 (+/-2.3) gms for WT mice and 24.8 (+/-4.1) gms for Myd88-/- mice. This difference in weight was not significant. Data shown are representative of two experiments.
###end p 56
###begin p 57
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 703 714 700 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g005">Figure 5A,B</xref>
###xml 813 818 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
In order to evaluate whether the enhanced responsiveness of Myd88-/- mice was a systemic feature of the Myd88-/- phenotype, we looked for evidence of heightened injury in another cell type susceptible to STZ damage-the hepatocyte. We evaluated aspartate transaminase (AST) and alanine transaminase (ALT) for the same time points as were evaluated with IPGTT. AST and ALT are liver transaminases which, when found in the peripheral circulation at elevated levels, are indicative of hepatocellular damage. We predicted that systemic administration of STZ would have a parallel impact on hepatocytes as on beta-cells, as both cell types are sensitive to STZ. This was indeed the case for both AST and ALT (Figure 5A,B). These data are consistent with systemic hyper-responsiveness to STZ treatment in the absence of Myd88-/- signaling.
###end p 57
###begin title 58
Transaminase Levels Following STZ Treatment.
###end title 58
###begin p 59
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g004">Figure 4</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
Data shown are for A. AST and B. ALT for 8 WT mice and 8 Myd88-/- mice who received low-dose STZ treatment for 4 days. The animals in this experiment were the same set of mice described in Figure 4 and data for the same time points 7, 14, and 24 days post completion of the low-dose STZ treatment course are shown.
###end p 59
###begin title 60
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Myd88-/- mice demonstrate enhanced beta -cell apoptosis following low-dose STZ treatment
###end title 60
###begin p 61
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 274 278 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-OBrien1">[41]</xref>
###xml 280 284 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Saini1">[42]</xref>
###xml 363 368 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 729 734 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 744 753 741 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g006">Figure 6A</xref>
###xml 776 785 773 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g006">Figure 6B</xref>
###xml 821 830 818 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g006">Figure 6E</xref>
###xml 859 864 856 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
The heightened cell damage observed in multiple tissue types in Myd88-/- animals raised the possibility that low-dose STZ treatment reflected an increased sensitivity to STZ-induced apoptosis. STZ is known to induce apoptotic cell death in hepatocytes as well as beta-cells [41], [42]. We therefore compared TUNEL staining in pancreases from low-dose STZ-treated Myd88-/- mice and WT controls. This was done for 6 sections from two mice from each group taken before and after low-dose STZ treatment for 11 days. No TUNEL-positive islet cells were seen in the sections taken from mice prior to STZ treatment (data not shown). However following low-dose STZ treatment we observed an increase in TUNEL positive cells in islets from Myd88-/- mice (Figure 6A) but not WT controls (Figure 6B). This difference was significant (Figure 6E). While it is possible that Myd88-/- mice develop impaired glycemic control more readily upon STZ treatment because they start with diminished beta cell mass, these data suggest their beta-cells are also more likely to undergo apoptosis under these conditions.
###end p 61
###begin title 62
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
TUNEL staining of pancreatic sections from WT and Myd88-/- mice following treatment with STZ.
###end title 62
###begin p 63
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
Data are shown for sections taken from A. Myd88-/- and B. WT mice on day 7 following completion of a low-dose STZ treatment. TUNEL staining is shown in green, insulin staining is shown in red and DAPI is shown in blue. C. Pooled data for the number of TUNEL staining cells per islet in Myd88-/- versus WT mice.
###end p 63
###begin title 64
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Myd88-/- mice do not have diminished levels of GLP-1
###end title 64
###begin p 65
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 159 163 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Wideman1">[43]</xref>
###xml 165 169 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Drucker1">[44]</xref>
###xml 297 306 294 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005063.s001">Figure S1</xref>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
To rule out a Myd88-dependent effect mediated by glucagon-like peptide-1 (GLP-1), a soluble factor known to promote beta-cell mass and insulin gene expression [43], [44], we analyzed GLP-1 concentrations in serum from mice both fasting (time = 0') and following IP glucose challenge (time = 90') (Figure S1). We did not find any differences in GLP-1 content between the two strains, suggesting that the findings reported here are not due to differences in GLP-1 expression.
###end p 65
###begin title 66
Low-dose oral LPS promotes glycemic control in animals with impaired commensal flora
###end title 66
###begin p 67
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-RakoffNahoum1">[7]</xref>
###xml 514 525 514 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g007">Figure 7A&#8211;B</xref>
###xml 886 895 886 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005063-g007">Figure 7C</xref>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
Based on the above data we hypothesized that commensal flora provide anti-apoptotic signals through Myd88-/-. This hypothesis predicts that denuding WT mice of their intestinal flora enhances sensitivity to low-dose STZ treatment and recapitulates the Myd88-/- phenotype. Therefore we administered a cocktail of broad spectrum antibiotics to WT animals for four weeks [7]. We found that these mice were normoglycemic before and after low-dose STZ treatment in comparison to mice which did not receive antibiotics (Figure 7A-B). Interestingly, we found that four weeks after the initiation of antibiotics we were still able to culture limited numbers of viable fecal bacteria. We then attempted to rescue TLR signaling in ABX treated mice by supplementing drinking water with LPS or LTA. We found that LPS supplementation of drinking water in these mice promoted tight glycemic control (Figure 7C). This effect was significant in the group of mice which received 10 ng/microl LPS but not in the groups recieving 10 microg/microl nor the group which received LTA. None of the mice in these experiments, either those which received antibiotics nor those which received antibiotics plus TLR ligands, demonstrated a significant change in their glycemic control from baseline upon IPGTT following low-dose STZ treatment (data not shown).
###end p 67
###begin title 68
Chronic broad-spectrum oral antibiotic treatment does not confer enhanced susceptibility to low-dose STZ treatment.
###end title 68
###begin p 69
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
Mice received a cocktail of oral antibiotics (vancomycin 500 mg/L, metronidazole 1 g/L, neomycin 1 g/L, and ampicillin 1 g/L in drinking water) for 4 weeks prior to STZ administration. IPGTT were performed prior to (A) and 7 days subsequent to (B) completion of a 4 day course of low dose STZ treatment. 8 mice were in each experimental arm. C.IPGTT results for mice who received daily supplementation of their drinking water with LTA at 100 ng/microl, LPS at 10 ug/microl, or LPS at 10 ng/microl in addition to supplementation with broad-spectrum antibiotics. The mice shown did not receive STZ. 8 mice were in each experimental arm. These experiments were performed twice with similar results.
###end p 69
###begin title 70
Discussion
###end title 70
###begin p 71
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Heald1">[45]</xref>
###xml 500 504 <span type="species:ncbi:10116">rats</span>
The first noteworthy finding of our manuscript is that TLRs and the signaling molecule Myd88 in particular may contribute to the regulation of islet mass. The histologic measurements reported here point to a loss of approximately 40% more islet volume in Myd88-/- animals as compared to WT controls on the same C57Bl/6 background. As TLR represent a major molecular interface between hosts and microbial flora, this finding may help explain an isolated report of diminished islet mass in gnotobiotic rats [45]. As no specific individual TLR was associated here individually with diminished islet mass, it may be that a combination of TLR make a contribution towards maintaining islet homeostasis in WT animals.
###end p 71
###begin p 72
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 136 141 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 325 330 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 389 396 386 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 413 418 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
The second finding of this work is that Myd88-/- mice were more likely than WT controls to develop hyperglycemia upon beta-cell insult. Myd88-/- mice became relatively hyperglycemic upon IPGTT following treatment with a low-dose STZ regimen. This is in contrast to the intact glycemic control seen here in healthy, uninjured Myd88-/- mice upon fasting IPGTT and evaluation of their islets ex vivo. It may be that Myd88-/- animals maintain adequate functional reserve to maintain glycemic control under normal circumstances and their reduced islet mass only become functionally relevant upon injury. This is consistent with models of diabetes in which the large majority of beta-cell mass must be lost before hyperglycemia is observed.
###end p 72
###begin p 73
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 385 393 385 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Gelman1">[46]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Francois1">[47]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Akira1">[48]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Lombardo1">[49]</xref>
###xml 691 696 691 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Aliprantis1">[50]</xref>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Sawa1">[51]</xref>
###xml 955 960 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Salaun1">[52]</xref>
###xml 1223 1226 1223 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Jiang1">[4]</xref>
###xml 1228 1231 1228 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Seki1">[5]</xref>
###xml 1233 1236 1233 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Macedo1">[6]</xref>
###xml 1238 1241 1238 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-RakoffNahoum1">[7]</xref>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
The third notable finding of this work is that Myd88-/- mice also have an increased rate of apoptosis upon low-dose STZ treatment,as Myd88-/- mice had greater numbers of apoptotic TUNEL positive cells per islet than WT controls. Both enhanced islet injury upon STZ treatment and diminished islet mass may contribute to the hyperglycemia seen here in Myd88-/- mice. The conclusion that Myd88-/- suffer greater injury upon STZ treatment is buttressed by the fact that they also displayed transaminitis indicative of hepatocyte damage. Myd88 mediated activation of NF-kB is known to promote cell survival via production of anti-apoptotic Bcl-2 family molecules [46], [47], [48], [49]. However, Myd88 also binds the Fas-associated Death Domain (FADD) and promotes induction of apoptosis via a pathway involving caspase 8 [50]. In the context of the pancreas, TLR4-/- mice were found to have reduced apoptosis in a surgical model of pancreatitis [51]. Whether Myd88 signaling contributes toward anti- or pro-apoptotic pathways is dependant on the particular TLR involved and other contextual cues [52]. While TLR have been found to contribute to the maintenance of tissue integrity at multiple sites of host-microbial interface [4], [5], [6], [7], these data extend this model to two tissue types not always considered to be part of that interface, the pancreatic islet and liver.
###end p 73
###begin p 74
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
The enhanced sensitivity to low-dose STZ was not recapitulated in WT mice denuded of intestinal flora upon the long-term administration of broad-spectrum antibiotics. Since this treatment did not render the intestines of these mice entirely sterile, it may be that even small quantities of intestinal bacteria are adequate. Alternatively, endogenous TLR ligands might suffice to maintain islet homeostasis upon STZ treatment in the setting of competent Myd88 signaling.
###end p 74
###begin p 75
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
Our data do not contradict the recent finding that the absence of Myd88 leads to changes in the penetrance of diabetes in NOD mice raised in either SPF or gnotobiotic conditions. In our work diabetes is induced by a toxin whereas diabetes in NOD mice is mediated by an autoimmune phenomenon. Together these data emphasize that effects of different TLR ligands and gut microbiota on diabetes are likely to be complex, multifactorial and dependent on the genetic underpinnings of the diabetes in question.
###end p 75
###begin p 76
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88&#8722;/&#8722;</italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
Our data also do not directly contradict the recent report that Myd88-/- mice developed an increased incidence of autoimmune diabetes relative to WT controls one to two months after low-dose STZ treatment. Notably those authors did not find relative hyperglycemia in Myd88-/- mice in the weeks immediately following low-dose STZ treatment but they measured blood glucose in fasting mice rather then upon glucose challenge via IPGTT as we have done here.
###end p 76
###begin p 77
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Cornell1">[53]</xref>
###xml 268 275 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 323 327 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-VivesPi1">[21]</xref>
###xml 685 689 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Arnush1">[54]</xref>
###xml 691 695 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Saitoh1">[55]</xref>
###xml 700 707 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 756 760 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Oguri1">[56]</xref>
###xml 1152 1156 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Cani1">[19]</xref>
###xml 1158 1162 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Creely1">[57]</xref>
###xml 1405 1409 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Ryan1">[58]</xref>
###xml 1501 1505 1488 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005063-Jacob1">[59]</xref>
###xml 208 212 <span type="species:ncbi:10116">rats</span>
###xml 1136 1142 <span type="species:ncbi:9606">humans</span>
###xml 1147 1151 <span type="species:ncbi:10116">rats</span>
We were intrigued to find that low-dose oral LPS has a salutary effect on glycemic control. These data are consistent with reports that endogenous gram negative bacteria tonically prime insulin production in rats [53] and consistent with data that treatment of islets ex vivo with LPS promotes beta-cell insulin production [21]. In that study the tonic effects of LPS on insulin secretion were dose dependant, with the lower concentrations being more beneficial. These effects were observed at LPS concentrations of 1-100 ng/ml, which is similar to that used to stimulate macrophages. At higher concentrations of LPS (e.g. 5-10 microg/ml) cytotoxic effect on islets have been observed [54], [55] and in vivo are associated with sepsis-induced hypoglycemia [56]. In sum, low-dose LPS appears to promotes insulin production and release while high dose LPS leads to stress-related responses. The dose-dependent nature of LPS effects on beta-cells may be clinically relevant during acute endotoxemic events and in settings of inflammation. Chronic inflammation and basal endotoxemia have been correlated with obesity and type 2 diabetes in humans and rats [19], [57]. Dose-dependant effects of endotoxin on beta-cells may also be relevant to the viability and function of transplanted islets. In the most commonly followed transplant protocol, endotoxins are infused into the portal circulation of recipients [58], where levels of endotoxin have been shown to be higher relative to peripheral circulation [59].
###end p 77
###begin p 78
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 282 287 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
We interpret the effects observed upon low-dose oral LPS treatment as functionally distinct from the role described here for Myd88 signaling in the setting of beta-cell injury. The salutary effect of oral LPS was apparent irrespective of STZ treatment and in the absence of injury. Myd88-/- mice, conversely, were phenotypically unremarkable until they received STZ. While these findings appear to describe distinct physiologic processes, they may be mechanistically related. Such overlap between pathways involved in beta-cell survival and beta-cell autoimmunity may account for the complex and sometimes contradictory relationship between infection and type 1 diabetes. Together these data suggest that TLRs and their ligands may play important roles in beta-cell physiology in both health and injury. They point towards an additional frontier in diabetes research, the role of microbial products in the regulation of glycemic control.
###end p 78
###begin title 79
Supporting Information
###end title 79
###begin p 80
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
Myd88-/- mice do not have diminished levels of GLP-1. Serum was taken from mice both fasting (time = 0') and following IP glucose challenge (time = 90') and subsequently analyzed for GLP-1 content. Data shown are for 12 WT mice and 8 Myd88-/- mice.
###end p 80
###begin p 81
(0.05 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
We would like to thank Anton Preisinger and Carrie Rosenberger for their technical assistance and helpful comments.
###end p 83
###begin title 84
References
###end title 84
###begin article-title 85
Toll-like receptors.
###end article-title 85
###begin article-title 86
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
Targeted disruption of the Myd88 gene results in loss of IL-1- and IL-18-mediated function.
###end article-title 86
###begin article-title 87
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Unresponsiveness of Myd88-deficient mice to endotoxin.
###end article-title 87
###begin article-title 88
Regulation of lung injury and repair by Toll-like receptors and hyaluronan.
###end article-title 88
###begin article-title 89
###xml 82 88 <span type="species:ncbi:10090">murine</span>
Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
###end article-title 89
###begin article-title 90
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Wound healing is impaired in Myd88-deficient mice: a role for Myd88 in the regulation of wound healing by adenosine A2A receptors.
###end article-title 90
###begin article-title 91
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.
###end article-title 91
###begin article-title 92
Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts.
###end article-title 92
###begin article-title 93
An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells.
###end article-title 93
###begin article-title 94
Induction of keratinocyte growth factor 1 Expression by lipopolysaccharide is regulated by CD-14 and toll-like receptors 2 and 4.
###end article-title 94
###begin article-title 95
###xml 73 78 <span type="species:ncbi:9606">human</span>
Keratinocyte growth factor (KGF)-1 and -2 protein and gene expression in human gingival fibroblasts.
###end article-title 95
###begin article-title 96
###xml 121 126 <span type="species:ncbi:9606">human</span>
Lipoteichoic acid and interleukin 1 stimulate synergistically production of hepatocyte growth factor (scatter factor) in human gingival fibroblasts in culture.
###end article-title 96
###begin article-title 97
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/Myd88/NF-IL6 pathway.
###end article-title 97
###begin article-title 98
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 23 29 <span type="species:ncbi:10090">murine</span>
Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are Myd88-dependent: role of the innate immune response in Celiac disease.
###end article-title 98
###begin article-title 99
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
###end article-title 99
###begin article-title 100
At the crossroads of inflammation and cancer.
###end article-title 100
###begin article-title 101
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.
###end article-title 101
###begin article-title 102
###xml 19 24 <span type="species:ncbi:9606">human</span>
Microbial ecology: human gut microbes associated with obesity.
###end article-title 102
###begin article-title 103
Metabolic endotoxemia initiates obesity and insulin resistance.
###end article-title 103
###begin article-title 104
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.
###end article-title 104
###begin article-title 105
Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells.
###end article-title 105
###begin article-title 106
The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets.
###end article-title 106
###begin article-title 107
###xml 53 57 <span type="species:ncbi:10116">rats</span>
Prevention of type I diabetes with lymphotoxin in BB rats.
###end article-title 107
###begin article-title 108
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 179 195 <span type="species:ncbi:562">Escherichia coli</span>
###xml 226 247 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
###end article-title 108
###begin article-title 109
###xml 111 115 <span type="species:ncbi:10090">mice</span>
The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
###end article-title 109
###begin article-title 110
Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes.
###end article-title 110
###begin article-title 111
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?
###end article-title 111
###begin article-title 112
Viral infections as potential triggers of type 1 diabetes.
###end article-title 112
###begin article-title 113
###xml 75 86 <span type="species:ncbi:10116">Wistar rats</span>
Poly I:C induction of alpha-interferon in the diabetes-prone BB and normal Wistar rats. Dose-response relationships.
###end article-title 113
###begin article-title 114
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Immunostimulation circumvents diabetes in NOD/Lt mice.
###end article-title 114
###begin article-title 115
Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells.
###end article-title 115
###begin article-title 116
Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
###end article-title 116
###begin article-title 117
###xml 144 147 <span type="species:ncbi:10116">rat</span>
Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver.
###end article-title 117
###begin article-title 118
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice.
###end article-title 118
###begin article-title 119
###xml 139 142 <span type="species:ncbi:10116">rat</span>
Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
###end article-title 119
###begin article-title 120
###xml 145 149 <span type="species:ncbi:10116">rats</span>
Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
###end article-title 120
###begin article-title 121
ImageJ for microscopy.
###end article-title 121
###begin article-title 122
###xml 30 33 <span type="species:ncbi:9606">man</span>
Islet isolation assessment in man and large animals.
###end article-title 122
###begin article-title 123
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
###end article-title 123
###begin article-title 124
Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora.
###end article-title 124
###begin article-title 125
Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
###end article-title 125
###begin article-title 126
###xml 85 91 <span type="species:ncbi:10090">murine</span>
Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1.
###end article-title 126
###begin article-title 127
Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1).
###end article-title 127
###begin article-title 128
Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis.
###end article-title 128
###begin article-title 129
The effect of gnotobiotic rearing on porcine islet isolation and function.
###end article-title 129
###begin article-title 130
Toll-like receptor ligands directly promote activated CD4+ T cell survival.
###end article-title 130
###begin article-title 131
Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad.
###end article-title 131
###begin article-title 132
Pathogen recognition and innate immunity.
###end article-title 132
###begin article-title 133
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
TLR4-mediated survival of macrophages is Myd88 dependent and requires TNF-alpha autocrine signalling.
###end article-title 133
###begin article-title 134
The apoptotic signaling pathway activated by Toll-like receptor-2.
###end article-title 134
###begin article-title 135
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Role of toll-like receptor 4 in the pathophysiology of severe acute pancreatitis in mice.
###end article-title 135
###begin article-title 136
Toll-like receptors' two-edged sword: when immunity meets apoptosis.
###end article-title 136
###begin article-title 137
###xml 102 106 <span type="species:ncbi:10116">rats</span>
Endogenous gut-derived bacterial endotoxin tonically primes pancreatic secretion of insulin in normal rats.
###end article-title 137
###begin article-title 138
###xml 47 52 <span type="species:ncbi:9606">human</span>
IL-1 produced and released endogenously within human islets inhibits beta cell function.
###end article-title 138
###begin article-title 139
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Serum thymic factor prevents LPS-induced pancreatic cell damage in mice via up-regulation of Bcl-2 expression in pancreas.
###end article-title 139
###begin article-title 140
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice.
###end article-title 140
###begin article-title 141
###xml 65 70 <span type="species:ncbi:9606">human</span>
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.
###end article-title 141
###begin article-title 142
Five-year follow-up after clinical islet transplantation.
###end article-title 142
###begin article-title 143
Endotoxin and bacteria in portal blood.
###end article-title 143
###begin p 144
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 144
###begin p 145
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the NIH (DK46635, HL18645, and DK53004) and the JDRF (The Center for Translational Research at BRI). PLB is supported by NIH K-08 grant DK080178-01 and an NIH LRP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 145

